Standard Kidney Function Tests Underestimate Chronic Kidney Disease in Cancer Patients

New research presented at ASN Kidney Week 2026 reveals that standard kidney function tests commonly used in clinical practice underestimate the prevalence of chronic kidney disease in people with cancer. This finding highlights the need for improved diagnostic methods to better assess kidney health in this vulnerable population.

Originally published by gnews